Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors [2]

American Journal of Human Genetics

Volumn 72, Issue 1, 2003, Pages 216-218

  Schneider Stock, Regine ^a   Giers, Anja ^a   Motsch, Christiane ^a   Boltze, Carsten ^a   Evert, Matthias ^a   Freigang, Bernd ^a   Roesnner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

CASE REPORT; DISEASE COURSE; GENE MUTATION; GENE REARRANGEMENT; HEAD AND NECK TUMOR; HETEROZYGOSITY; HUMAN; LETTER; MALE; METHYLATION; MOUTH CARCINOMA; PHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0037218954     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/345397     Document Type: Letter

References (14)

1. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61:939-942
2. Esteller M, Corn PG, Maylin SB, Herman JG (2001a) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229
3. Esteller M, Fraga M, Guo M, Gacia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG (2001b) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 10:3001-3007
4. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S (2000) Methylation of the CDH1 promotor as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26:16-17
5. Gruis NA, van der Velden P, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10:351-353
6. Herman JG, Graft JR, Myohänen S, Nelkin BD, Maylin SB (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
7. Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S (2000) Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chrom Cancer 27:358-361
8. Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, Li L, Knezetic J, Lassam NJ, Goggins M, Kern S (2002) Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: The familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 94:84-96
9. Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, Pearl DK, Casto B, Tsai MD, Weghorst CM (2001) Somatic INK4a-ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog 30:26-36
10. Sambrook J, Fritsch EF, Maniatis T (2nd ed) (1989) Molecular Cloning - A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
11. Schneider-Stock R, Walter H, Haeckel C, Radig K, Rys J, Roessner A (1998) Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors. Int J Oncol 13:325-329
12. van der Velden PA, Sandkuijl LA, Bergman W, Hille ETM, Frants RR, Gruis NA (1999) A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families. Genome Res 9:575-580
13. van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA (2001) Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69:774-779
14. Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM, Bergman W (2000) Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 87:809-811